期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 30, 期 22, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2020.127582
关键词
Nitroimidazole; Xanthate; Tc-99m; Tumor; Hypoxia; SPECT imaging
资金
- National Natural Science Foundation of China [21771023]
- Beijing Municipal Science and Technology Commission [Z181100002218033]
A 4-nitroimidazole xanthate ligand (NMXT) was synthesized and radiolabeled with [(TcN)-Tc-99m](2) core and [(TcO)-Tc-99m](3+) core to obtain (TcN)-Tc-99m-NMXT and (TcO)-Tc-99m-NMXT, respectively. The two Tc-99m-complexes were prepared with high radiochemical purity and had good stability. The partition coefficient results indicated both of them were hydrophilic, and cellular uptake studies showed they exhibited good hypoxic selectivity. From the biodistribution study results, (TcO)-Tc-99m-NMXT showed more favourable tumor uptake (1.73 +/- 0.14 ID%/g) and higher tumor/muscle ratio (7.01 +/- 0.16) than (TcN)-Tc-99m-NMXT at 4 h post-injection. Single photon emission computed tomography (SPECT) imaging study of (TcO)-Tc-99m-NMXT showed there was a visible accumulation in tumor site, suggesting it would be a promising candidate as a tumor hypoxia imaging agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据